Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H40NO.Br |
| Molecular Weight | 414.463 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Br-].CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1
InChI
InChIKey=OJIYIVCMRYCWSE-UHFFFAOYSA-M
InChI=1S/C22H40NO.BrH/c1-4-5-6-7-8-9-10-11-12-16-19-23(2,3)20-21-24-22-17-14-13-15-18-22;/h13-15,17-18H,4-12,16,19-21H2,1-3H3;1H/q+1;/p-1
Domiphen bromide it is used for the treatment of Acute Infectious Dental Diseases. Domiphen bromide is a quaternary antiseptic with actions and uses similar to those of cationic surfactants. Domiphen bromide has potent activity on blockade of human ether-a-go-go related gene (HERG) channels.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL240 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24846011 |
9.0 nM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | Bradosol Approved UseUnknown |
|||
| Curative | EXODEN POWDER Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Antimicrobial peptides from arachnid venoms and their microbicidal activity in the presence of commercial antibiotics. | 2013-01 |
|
| Rational development of taste masked oral liquids guided by an electronic tongue. | 2010-11-15 |
|
| No detectable effect of RNA-binding protein Hfq absence in Staphylococcus aureus. | 2007-02-09 |
|
| Characterization of micelle formation of dodecyldimethyl-N-2-phenoxyethylammonium bromide in aqueous solution. | 2006-06-01 |
|
| A reversed phase HPLC assay for the simultaneous quantitation of non-ionic and ionic surfactants in bioprocess intermediates. | 2006-03-03 |
|
| Separation of fulvic acid from soil extracts based on ion-pair formation with a cationic surfactant. | 2006-02 |
|
| Development of a novel adenovirus purification process utilizing selective precipitation of cellular DNA. | 2005-07-05 |
|
| 5-Dodecanoylaminofluorescein as a probe for the determination of critical micelle concentration of detergents using fluorescence anisotropy. | 2005-05-15 |
|
| Occupational allergic contact dermatitis from alkylammonium amidobenzoate. | 2001-05-19 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C83486
Created by
admin on Mon Mar 31 17:33:55 GMT 2025 , Edited by admin on Mon Mar 31 17:33:55 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
39415
Created by
admin on Mon Mar 31 17:33:55 GMT 2025 , Edited by admin on Mon Mar 31 17:33:55 GMT 2025
|
PRIMARY | |||
|
10866
Created by
admin on Mon Mar 31 17:33:55 GMT 2025 , Edited by admin on Mon Mar 31 17:33:55 GMT 2025
|
PRIMARY | |||
|
SUB06356MIG
Created by
admin on Mon Mar 31 17:33:55 GMT 2025 , Edited by admin on Mon Mar 31 17:33:55 GMT 2025
|
PRIMARY | |||
|
7236
Created by
admin on Mon Mar 31 17:33:55 GMT 2025 , Edited by admin on Mon Mar 31 17:33:55 GMT 2025
|
PRIMARY | |||
|
DBSALT001884
Created by
admin on Mon Mar 31 17:33:55 GMT 2025 , Edited by admin on Mon Mar 31 17:33:55 GMT 2025
|
PRIMARY | |||
|
100000080778
Created by
admin on Mon Mar 31 17:33:55 GMT 2025 , Edited by admin on Mon Mar 31 17:33:55 GMT 2025
|
PRIMARY | |||
|
49255
Created by
admin on Mon Mar 31 17:33:55 GMT 2025 , Edited by admin on Mon Mar 31 17:33:55 GMT 2025
|
PRIMARY | RxNorm | ||
|
538-71-6
Created by
admin on Mon Mar 31 17:33:55 GMT 2025 , Edited by admin on Mon Mar 31 17:33:55 GMT 2025
|
PRIMARY | |||
|
C007556
Created by
admin on Mon Mar 31 17:33:55 GMT 2025 , Edited by admin on Mon Mar 31 17:33:55 GMT 2025
|
PRIMARY | |||
|
R4CY19YS7C
Created by
admin on Mon Mar 31 17:33:55 GMT 2025 , Edited by admin on Mon Mar 31 17:33:55 GMT 2025
|
PRIMARY | |||
|
2730
Created by
admin on Mon Mar 31 17:33:55 GMT 2025 , Edited by admin on Mon Mar 31 17:33:55 GMT 2025
|
PRIMARY | |||
|
R4CY19YS7C
Created by
admin on Mon Mar 31 17:33:55 GMT 2025 , Edited by admin on Mon Mar 31 17:33:55 GMT 2025
|
PRIMARY | |||
|
DOMIPHEN BROMIDE
Created by
admin on Mon Mar 31 17:33:55 GMT 2025 , Edited by admin on Mon Mar 31 17:33:55 GMT 2025
|
PRIMARY | |||
|
CHEMBL1187011
Created by
admin on Mon Mar 31 17:33:55 GMT 2025 , Edited by admin on Mon Mar 31 17:33:55 GMT 2025
|
PRIMARY | |||
|
208-702-0
Created by
admin on Mon Mar 31 17:33:55 GMT 2025 , Edited by admin on Mon Mar 31 17:33:55 GMT 2025
|
PRIMARY | |||
|
C72644
Created by
admin on Mon Mar 31 17:33:55 GMT 2025 , Edited by admin on Mon Mar 31 17:33:55 GMT 2025
|
PRIMARY | |||
|
m4734
Created by
admin on Mon Mar 31 17:33:55 GMT 2025 , Edited by admin on Mon Mar 31 17:33:55 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID5033468
Created by
admin on Mon Mar 31 17:33:55 GMT 2025 , Edited by admin on Mon Mar 31 17:33:55 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD